AP01 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Pirfenidone Solution

Pipeline

Phase 2: 1

Top Sponsors

Avalyn Pharma Inc.1

Indications

Interstitial Lung Disease With Systemic Sclerosis1
Hypersensitivity Pneumonitis1
Pulmonary Fibrosis, Interstitial Lung Disease1
Pulmonary Fibrosis Secondary to Systemic Sclerosis1
Progressive Pulmonary Fibrosis1

Birmingham, Alabama1 trial

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.